Vivos Therapeutics Announces Exchange Of $2,861,270 Of Streeterville Note Principal For 11,445,080 Common Shares At $0.25/Share
Share
Why It Matters
Vivos Therapeutics traded about $2.9 million of debt (money it owes) for new shares of company ownership, like swapping an IOU for a piece of the pie. When companies do this, watch whether it helps them stay afloat or if it means they're running low on cash.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.